人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 牛ELISA试剂盒| 猪ELISA试剂盒| 鸡ELISA试剂盒| 犬ELISA试剂盒| 猫ELISA试剂盒| 马ELISA试剂盒| 植物ELISA试剂盒| 山羊ELISA试剂盒| 绵羊ELISA试剂盒| 鸭ELISA试剂盒| 兔ELISA试剂盒| 鱼ELISA试剂盒| 豚鼠ELISA试剂盒| 鹅ELISA试剂盒| 药物残留ELISA试剂盒| 兽药残留快速检测卡| 毒素类ELISA试剂盒| 其他ELISA试剂盒| Human ELISA Kit| Rat ELISA Kit| Mouse ELISA Kit| Procine ELISA Kit| Rabbit ELISA Kit| Guinea ELISA Kit| Chicken ELISA Kit| Sheep ELISA Kit| Canine ELISA Kit| 其它ELISA试剂盒|
高敏人Elisa试剂盒| 高敏小鼠Elisa试剂盒| 高敏大鼠Elisa试剂盒| 高敏豚鼠Elisa试剂盒| 高敏裸鼠Elisa试剂盒| 高敏仓鼠Elisa试剂盒| 高敏沙鼠Elisa试剂盒| 高敏鸭Elisa试剂盒| 高敏鹅Elisa试剂盒| 高敏猴Elisa试剂盒| 高敏兔Elisa试剂盒| 高敏马Elisa试剂盒| 高敏绵羊Elisa试剂盒| 高敏山羊Elisa试剂盒| 高敏犬Elisa试剂盒| 高敏牛Elisa试剂盒| 高敏鱼Elisa试剂盒|
微量法检测系列| 细胞生物学| 分子生物学| 物质分析| 病理学| 免疫学| 病毒包装| 动物造模| 蛋白表达| 抗体制备| 文库构建和筛选| RACE实验| 杂交实验| HPLC法检测项目| 气相色谱法检测项目|
染色液| 固定液| 染料| 褐藻寡糖系列| 壳寡糖系列| 琼胶寡糖系列| 卡拉胶寡糖系列| 木寡糖系列| 棉籽半乳寡糖系列| 不饱和硫酸软骨素二糖系列| 透明质酸寡糖系列| 麦芽寡糖系列| 海洋寡糖原料类|
细胞技术类产品| 生化试剂盒| 分子技术类产品| 蛋白化学技术类产品| 免疫抗体技术类产品| 医学技术类产品| 病理技术类产品| 生物化学技术类产品| 模式生物技术类产品| 微生物技术类产品| 植物技术类产品| 载体技术类产品| 毒理技术类产品| 营养技术类产品| 平台技术类产品| 其他相关产品|
蛋白质类| 氨基酸&多肽&蛋白质| 抗生素(生化试剂)| 酶&辅酶&抑制剂| 动植物激素| 碳水化合物及衍生物| 色素类| 维生素| 分离材料及耗材| 表面活性剂| 缓冲溶剂| 其他化学试剂| 碱基&核酸及其衍生物| 酸&盐&胺| 常规生化试剂|
细胞生长因子| 细胞辅助试剂| 细胞培养| 细胞检测试剂| 细胞系(株)| 细胞分离与消化| 细胞染色与探针| 细胞转染| 鲎试剂| 免疫细胞及干细胞| 其他原代细胞| 小鼠原代细胞| 大鼠原代细胞| 人源原代细胞| 其他细胞系| 小鼠细胞系| 大鼠细胞系| 人源细胞系|
农药标准物质| 天然药物系列单体| 英国LGC标准品| 美国药典标准品| 中检所标准品| 中药对照品| 对照药材| 标准溶液| 进口标准品| 分析对照品| 衍生化试剂| 离子对试剂|
| 靶标 | FTO |
| 别名 | AlkB homolog 9; ALKBH9; Alpha-ketoglutarate-dependent dioxygenase FTO; AW743446; Fat mass and obesity-associated protein; FATSO, MOUSE, HOMOLOG OF; Fto; FTO_HUMAN; GDFD; KIAA1752; mKIAA1752; Protein fatso; |
| 宿主 | Rabbit |
| 稀释比例 | WB 1:1000-3000. IHC 1:50-200. |
| Gene ID | 79068 |
| 保存 | Store at -20°C. Avoid freeze / thaw cycles. |
| Swiss Prot | Q9C0B1 |
| 蛋白分子量 | 7/12/15/58kDa |
| 储存液 | Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3. |
| 亚细胞定位 | Cytoplasm Nucleus |
| 免疫原 | A synthetic peptide of human FTO |
| 亚型 | IgG |
| 纯化方法 | Affinity purification |
| 背景资料 | RNA demethylase that mediates oxidative demethylation of different RNA species, such as mRNAs, tRNAs and snRNAs, and acts as a regulator of fat mass, adipogenesis and energy homeostasis (PubMed:22002720, PubMed:26458103, PubMed:28002401, PubMed:30197295, PubMed:26457839, PubMed:25452335). Specifically demethylates N6-methyladenosine (m6A) RNA, the most prevalent internal modification of messenger RNA (mRNA) in higher eukaryotes (PubMed:22002720, PubMed:26458103, PubMed:30197295, PubMed:26457839, PubMed:25452335). M6A demethylation by FTO affects mRNA expression and stability (PubMed:30197295). Also able to demethylate m6A in U6 small nuclear RNA (snRNA) (PubMed:30197295). Mediates demethylation of N6,2'-O-dimethyladenosine cap (m6A(m)), by demethylating the N6-methyladenosine at the second transcribed position of mRNAs and U6 snRNA (PubMed:28002401, PubMed:30197295). Demethylation of m6A(m) in the 5'-cap by FTO affects mRNA stability by promoting susceptibility to decapping (PubMed:28002401). Also acts as a tRNA demethylase by removing N1-methyladenine from various tRNAs (PubMed:30197295). Has no activity towards 1-methylguanine (PubMed:20376003). Has no detectable activity towards double-stranded DNA (PubMed:20376003). Also able to repair alkylated DNA and RNA by oxidative demethylation: demethylates single-stranded RNA containing 3-methyluracil, single-stranded DNA containing 3-methylthymine and has low demethylase activity towards single-stranded DNA containing 1-methyladenine or 3-methylcytosine (PubMed:18775698, PubMed:20376003). Ability to repair alkylated DNA and RNA is however unsure in vivo (PubMed:18775698, PubMed:20376003). Involved in the regulation of fat mass, adipogenesis and body weight, thereby contributing to the regulation of body size and body fat accumulation (PubMed:18775698, PubMed:20376003). Involved in the regulation of thermogenesis and the control of adipocyte differentiation into brown or white fat cells (PubMed:26287746). Regulates activity of the dopaminergic midbrain circuitry via its ability to demethylate m6A in mRNAs (By similarity). Plays an oncogenic role in a number of acute myeloid leukemias by enhancing leukemic oncogene-mediated cell transformation: acts by mediating m6A demethylation of target transcripts such as MYC, CEBPA, ASB2 and RARA, leading to promote their expression (PubMed:28017614, PubMed:29249359). |
| Public Immunogen Range | 190-240/505 |
| 克隆类型 | Polyclonal Antibody |
| 交叉反应 | HumanPredicted:Chimpanzee DogRatMouse |
| 应用 | WBIHC |
| 规格 | 50ul100ul |